This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-let-7a-5p | TARBP2 | -0 | 0.98266 | -0.14 | 0.00414 | TargetScan | -0.11 | 0.00044 | NA | |
2 | hsa-miR-326 | TARBP2 | 0.63 | 9.0E-5 | -0.14 | 0.00414 | miRanda | -0.11 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | POSITIVE REGULATION OF GENE EXPRESSION | 23 | 1733 | 2.159e-10 | 1.005e-06 |
2 | REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 11 | 354 | 5.994e-09 | 1.395e-05 |
3 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 21 | 1805 | 1.853e-08 | 2.215e-05 |
4 | POSITIVE REGULATION OF MULTI ORGANISM PROCESS | 8 | 157 | 1.904e-08 | 2.215e-05 |
5 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 11 | 448 | 6.702e-08 | 6.236e-05 |
6 | REGULATION OF VIRAL GENOME REPLICATION | 6 | 75 | 8.731e-08 | 6.771e-05 |
7 | REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM | 8 | 205 | 1.505e-07 | 8.083e-05 |
8 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 18 | 1492 | 1.563e-07 | 8.083e-05 |
9 | POSTTRANSCRIPTIONAL GENE SILENCING | 5 | 42 | 1.47e-07 | 8.083e-05 |
10 | REGULATION OF KINASE ACTIVITY | 13 | 776 | 3.172e-07 | 0.0001233 |
11 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 14 | 917 | 3.179e-07 | 0.0001233 |
12 | POSITIVE REGULATION OF VIRAL PROCESS | 6 | 92 | 2.975e-07 | 0.0001233 |
13 | REGULATION OF GENE SILENCING BY RNA | 4 | 21 | 3.937e-07 | 0.0001308 |
14 | REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING | 4 | 21 | 3.937e-07 | 0.0001308 |
15 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 18 | 1618 | 5.221e-07 | 0.0001619 |
16 | REGULATION OF MULTI ORGANISM PROCESS | 10 | 470 | 1.046e-06 | 0.0003042 |
17 | POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 4 | 30 | 1.767e-06 | 0.0004837 |
18 | RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION | 7 | 199 | 1.913e-06 | 0.0004945 |
19 | NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 6 | 131 | 2.386e-06 | 0.0005609 |
20 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 14 | 1087 | 2.411e-06 | 0.0005609 |
21 | REGULATION OF TRANSFERASE ACTIVITY | 13 | 946 | 2.918e-06 | 0.0006464 |
22 | REGULATION OF CELL DIFFERENTIATION | 16 | 1492 | 4.298e-06 | 0.000909 |
23 | REGULATION OF CHROMOSOME SEGREGATION | 5 | 85 | 5.146e-06 | 0.00104 |
24 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 13 | 1004 | 5.589e-06 | 0.00104 |
25 | REGULATION OF PROTEIN MODIFICATION PROCESS | 17 | 1710 | 5.522e-06 | 0.00104 |
26 | PRE MIRNA PROCESSING | 3 | 13 | 6.829e-06 | 0.001222 |
27 | DEFENSE RESPONSE TO VIRUS | 6 | 164 | 8.725e-06 | 0.001504 |
28 | RESPONSE TO CORTICOSTEROID | 6 | 176 | 1.305e-05 | 0.002169 |
29 | SINGLE ORGANISM BEHAVIOR | 8 | 384 | 1.619e-05 | 0.00258 |
30 | REGULATION OF GENE SILENCING | 4 | 52 | 1.663e-05 | 0.00258 |
31 | NEURON PROJECTION MORPHOGENESIS | 8 | 402 | 2.249e-05 | 0.003376 |
32 | GROWTH | 8 | 410 | 2.589e-05 | 0.003655 |
33 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 11 | 829 | 2.629e-05 | 0.003655 |
34 | RHYTHMIC PROCESS | 7 | 298 | 2.671e-05 | 0.003655 |
35 | CELL DEATH | 12 | 1001 | 2.926e-05 | 0.003782 |
36 | NEURON PROJECTION DEVELOPMENT | 9 | 545 | 2.897e-05 | 0.003782 |
37 | RESPONSE TO NITROGEN COMPOUND | 11 | 859 | 3.641e-05 | 0.004344 |
38 | DSRNA FRAGMENTATION | 3 | 22 | 3.608e-05 | 0.004344 |
39 | PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA | 3 | 22 | 3.608e-05 | 0.004344 |
40 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 12 | 1036 | 4.096e-05 | 0.004648 |
41 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 12 | 1036 | 4.096e-05 | 0.004648 |
42 | RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 8 | 440 | 4.274e-05 | 0.004735 |
43 | REGULATION OF CATABOLIC PROCESS | 10 | 731 | 4.968e-05 | 0.005376 |
44 | CELL DEVELOPMENT | 14 | 1426 | 5.218e-05 | 0.005518 |
45 | DEVELOPMENTAL GROWTH | 7 | 333 | 5.406e-05 | 0.005589 |
46 | RESPONSE TO ORGANOPHOSPHORUS | 5 | 139 | 5.587e-05 | 0.005651 |
47 | REGULATION OF GENE EXPRESSION EPIGENETIC | 6 | 229 | 5.729e-05 | 0.005672 |
48 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 12 | 1079 | 6.074e-05 | 0.005767 |
49 | RESPONSE TO DSRNA | 4 | 72 | 6.05e-05 | 0.005767 |
50 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 8 | 465 | 6.302e-05 | 0.005865 |
51 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 8 | 470 | 6.792e-05 | 0.006197 |
52 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 5 | 146 | 7.056e-05 | 0.006314 |
53 | NEGATIVE REGULATION OF GENE EXPRESSION | 14 | 1493 | 8.579e-05 | 0.007362 |
54 | PROTEIN PHOSPHORYLATION | 11 | 944 | 8.532e-05 | 0.007362 |
55 | RESPONSE TO VIRUS | 6 | 247 | 8.702e-05 | 0.007362 |
56 | CELL PART MORPHOGENESIS | 9 | 633 | 9.202e-05 | 0.007591 |
57 | NEGATIVE REGULATION OF KINASE ACTIVITY | 6 | 250 | 9.299e-05 | 0.007591 |
58 | RESPONSE TO STEROID HORMONE | 8 | 497 | 0.0001002 | 0.007908 |
59 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 7 | 368 | 0.0001011 | 0.007908 |
60 | RESPONSE TO PURINE CONTAINING COMPOUND | 5 | 158 | 0.0001025 | 0.007908 |
61 | NEGATIVE REGULATION OF CELL PROLIFERATION | 9 | 643 | 0.0001037 | 0.007908 |
62 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 8 | 513 | 0.0001246 | 0.009354 |
63 | BEHAVIOR | 8 | 516 | 0.0001297 | 0.009583 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | DOUBLE STRANDED RNA BINDING | 7 | 64 | 7.336e-10 | 6.815e-07 |
2 | RNA BINDING | 19 | 1598 | 7.941e-08 | 3.689e-05 |
3 | MRNA BINDING | 6 | 155 | 6.313e-06 | 0.001173 |
4 | ADENOSINE DEAMINASE ACTIVITY | 3 | 11 | 3.957e-06 | 0.001173 |
5 | POLY A RNA BINDING | 14 | 1170 | 5.665e-06 | 0.001173 |
6 | MRNA 3 UTR BINDING | 4 | 48 | 1.206e-05 | 0.001868 |
7 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 7 | 315 | 3.803e-05 | 0.005047 |
8 | PRE MRNA BINDING | 3 | 24 | 4.723e-05 | 0.005484 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | SITE OF POLARIZED GROWTH | 6 | 149 | 5.03e-06 | 0.002937 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Sphingolipid_signaling_pathway_hsa04071 | 5 | 118 | 2.549e-05 | 0.0009797 | |
2 | Autophagy_animal_hsa04140 | 5 | 128 | 3.768e-05 | 0.0009797 | |
3 | TGF_beta_signaling_pathway_hsa04350 | 4 | 84 | 0.0001105 | 0.001916 | |
4 | Wnt_signaling_pathway_hsa04310 | 4 | 146 | 0.0009083 | 0.01181 | |
5 | PI3K_Akt_signaling_pathway_hsa04151 | 5 | 352 | 0.003775 | 0.03474 | |
6 | Autophagy_other_hsa04136 | 2 | 32 | 0.004009 | 0.03474 | |
7 | Oocyte_meiosis_hsa04114 | 3 | 124 | 0.005873 | 0.04181 | |
8 | FoxO_signaling_pathway_hsa04068 | 3 | 132 | 0.006978 | 0.04181 | |
9 | Apelin_signaling_pathway_hsa04371 | 3 | 137 | 0.007728 | 0.04181 | |
10 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 3 | 139 | 0.008041 | 0.04181 | |
11 | Hippo_signaling_pathway_hsa04390 | 3 | 154 | 0.01062 | 0.05022 | |
12 | Necroptosis_hsa04217 | 3 | 164 | 0.01258 | 0.05452 | |
13 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.0158 | 0.06319 | |
14 | Adherens_junction_hsa04520 | 2 | 72 | 0.01916 | 0.07116 | |
15 | NF_kappa_B_signaling_pathway_hsa04064 | 2 | 95 | 0.03206 | 0.1111 | |
16 | HIF_1_signaling_pathway_hsa04066 | 2 | 100 | 0.03521 | 0.1144 | |
17 | AMPK_signaling_pathway_hsa04152 | 2 | 121 | 0.04967 | 0.1519 | |
18 | Apoptosis_hsa04210 | 2 | 138 | 0.06267 | 0.181 | |
19 | mTOR_signaling_pathway_hsa04150 | 2 | 151 | 0.0733 | 0.2006 | |
20 | Cellular_senescence_hsa04218 | 2 | 160 | 0.08097 | 0.2048 | |
21 | Jak_STAT_signaling_pathway_hsa04630 | 2 | 162 | 0.08271 | 0.2048 | |
22 | Tight_junction_hsa04530 | 2 | 170 | 0.08978 | 0.2102 | |
23 | cAMP_signaling_pathway_hsa04024 | 2 | 198 | 0.1158 | 0.2429 | |
24 | Focal_adhesion_hsa04510 | 2 | 199 | 0.1168 | 0.2429 | |
25 | Regulation_of_actin_cytoskeleton_hsa04810 | 2 | 208 | 0.1255 | 0.2458 |